OpGen Balance Sheet Health
Financial Health criteria checks 4/6
OpGen has a total shareholder equity of $3.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.5M and $2.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.63m |
| Equity | US$2.99m |
| Total liabilities | US$2.48m |
| Total assets | US$5.47m |
Recent financial health updates
Recent updates
OpGen to raise $3.38M in direct stock offering
Sep 30OpGen's subsidiary signs R&D agreement with FIND
Sep 20Nasdaq grants extension to OpGen to regain compliance with minimum bid price requirement
Aug 31OpGen launches sequencing services for infectious diseases in US
Aug 25OpGen GAAP EPS of -$0.13 beats by $0.02, revenue of $1M in-line
Aug 11OpGen reports preliminary revenue estimate for Q2 2022
Jul 08OpGen gains on insider buying
Jun 15OpGen submits 510(k) summary to FDA for Acuitas AMR Gene Panel for Isolates
Jun 07OpGen reports prelim Q4 & FY20 revenue
Jan 13OpGen subsidiary Curetis and Annar ink Unyvero distribution partnership for Colombia
Jan 05OpGen launches $10M private placement
Nov 24OpGen EPS misses by $0.04, beats on revenue
Nov 11OpGen's subsidiary and collaborators secures German funding to develop such a molecular diagnostics platform
Oct 28Financial Position Analysis
Short Term Liabilities: OPGN's short term assets ($3.2M) exceed its short term liabilities ($589.8K).
Long Term Liabilities: OPGN's short term assets ($3.2M) exceed its long term liabilities ($1.9M).
Debt to Equity History and Analysis
Debt Level: OPGN is debt free.
Reducing Debt: OPGN currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OPGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: OPGN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.7% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 23:19 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OpGen, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| null null | Brookline Capital Markets |
| Nidhi Singh | Edison Investment Research |